Bolt Biotherapeutics (BOLT) Stock Performance ; Bolt Biotherapeutics (BOLT). , ; S&P BSE Sensex · , ; S&P Small-Cap · , Mar PM · Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies. (Benzinga) ; Mar PM · Bolt Biotherapeutics Reports. Get Bolt Biotherapeutics Inc (777qiuqiu.online) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Bolt Biotherapeutics (BOLT) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.

On average, Wall Street analysts predict that Bolt Biotherapeutics's share price could reach $ by May 15, The average Bolt Biotherapeutics stock price. Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC. Proposed Symbol, Company Name, BOLT INC. Exchange, Nasdaq National Market. Share Price, $ Employees, (as of 02/29/). Status, Withdrawn. Thinking of buying or selling Bolt Biotherapeutics stock that's listed in a currency different from your local one? Use our international stock ticker to. Institutional Ownership and Shareholders. Bolt Biotherapeutics, Inc. (US:BOLT) has 59 institutional owners and shareholders that have filed 13D/G or 13F forms. Currently, Wall Street analysts rate BOLT as Neutral on average. Additionally, the current consensus price target from analysts is $ To see all of BOLT's. Bolt Biotherapeutics Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M. Buy Bolt Biotherapeutics Inc Shares from India at $ (0 Commission) today. Start investing in Bolt Biotherapeutics Inc stocks from India now with. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Bolt Biotherapeutics, Inc Chesapeake Drive Redwood City, CA Phone: View the latest Bolt Biotherapeutics Inc. (BOLT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Bolt Biotherapeutics Second Quarter Earnings: Misses Expectations. Bolt Biotherapeutics (NASDAQ:BOLT) Second Quarter Results Key Financial Results.

Bolt Biotherapeutics stock was originally listed at a price of $ in Feb 8, If you had invested in Bolt Biotherapeutics stock at $, your return. Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. View today's Bolt Biotherapeutics stock price and latest BOLT news and analysis. Create real-time notifications to follow any changes in the live stock. Based on 5 Wall Street analysts offering 12 month price targets for Bolt Biotherapeutics in the last 3 months. The average price target is $ with a high. Stock analysis for Bolt Biotherapeutics Inc (BOLT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Research Bolt Biotherapeutics' (Nasdaq:BOLT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Get Bolt Biotherapeutics Inc (BOLT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) posted its quarterly earnings data on Tuesday, May, 14th. The company reported ($) earnings per share (EPS) for the. Historical BOLT Price Data ; 6 Months, , , , ; 1 Year, , , ,

Bolt Biotherapeutics Inc. (NASDAQ: BOLT). $ (%) K. At close: Jun 25, , 4. BOLT | Complete Bolt Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get the latest Bolt Biotherapeutics Inc (BOLT) real-time quote, historical performance, charts, and other financial information to help you make more. Get started to view real-time data on Bolt Finance stock including most recent valuation and historical share price information. Get Started. Leverage Your. BOLT's current price target is $ Learn why top analysts are making this stock forecast for Bolt Biotherapeutics at MarketBeat.

online sberbank | robotic assistance devices stock

7 8 9 10 11

Copyright 2011-2024 Privice Policy Contacts SiteMap RSS

good 200